High serum TGF-α predicts poor response to lapatinib and capecitabine in HER2-positive breast cancer.
Rhee
Jiyoung
J
Department of Internal Medicine, Seoul National University Hospital, 101 Daehang-Ro, Jongno-Gu, Seoul, Korea.
Han
Sae-Won
SW
Cha
Yongjun
Y
Ham
Hye Seon
HS
Kim
Hwang-phill
HP
Oh
Do-Youn
DY
Im
Seock-Ah
SA
Park
Jong-Wan
JW
Ro
Jungsil
J
Lee
Keun Seok
KS
Park
In Hae
IH
Im
Young-Hyuck
YH
Bang
Yung-Jue
YJ
Kim
Tae-You
TY